Agenda
For Symposium times and other information, Read More

   
 

Symposium Speakers
For a list of the speakers, Read More

   
 

History of Philadelphia Chromosome
For a history of the seminal discovery, Read More

   
 

Related Links & Timeline
For useful links and a timeline, Read More

The study of the Philadelphia Chromosome has provided essential insights into the role of chromosome changes in cancer. The initial discovery of this abnormal chromosome and its association with chronic myeloid leukemia sparked the search for additional abnormalities that might consistently correlate with particular types of leukemia, lymphoma or other tumors.

-Janet Rowley, University of Chicago, in the Fox Chase Cancer Center publication, Special Edition

Speakers & Honorary Guests

Jeff Boyd, PhD
Executive Director,
Institute of Personalized Medicine,
The Robert C. Young, MD Chair in Cancer Research
Fox Chase Cancer Center, Philadelphia, PA

Jennifer J.D. Morrissette, PhD, FACMG
Scientific Director, Clinical Cancer Cytogenetics,
University of Pennsylvania,
Philadelphia, PA

H. Sharat Chandra, PhD
Professor Emeritus, Indian Institute of Science;
Honorary Director, Centre for Human Genetics,
Bangalore, India

Peter C. Nowell, MD
Gaylord and Mary Louise Harnwell Emeritus Professor of Pathology and Laboratory Medicine,
University of Pennsylvania, School of Medicine,
Philadelphia, PA

Brian J. Druker, MD
Director, Oregon Health & Science University,
Knight Cancer Institute,
JELD-WEN Chair of Leukemia Research,
Investigator, Howard Hughes Medical Institute
Portland, OR

Janet D. Rowley, MD
Blum-Riese Distinguished Service Professor of Medicine,
Molecular Genetics & Cell Biology, Human Genetics,
The University of Chicago
Chicago, IL

Emeritus Professor John M. Goldman, DM, FRCP, FRCPath, FMedSci
Senior Research Investigator, Division of Investigative Science,
Imperial College London,
London, United Kingdom

Charles L. Sawyers, MD
Investigator, Howard Hughes Medical Institute Chairman, Human Oncology & Pathogenesis Program Memorial Sloan-Kettering Cancer Center,
New York, NY

Nora C. Heisterkamp, PhD
Professor of Pediatrics and Pathology,
Division of Hematology-Oncology,
Children’s Hospital of Los Angeles
Los Angeles, Ca

William R. Sellers, MD
Vice President & Global Head of Oncology
Novartis Institutes of BioMedical Research, Inc.
Cambridge, MA

Mrs. David A. (Alice) Hungerford, BA
ECRI Institute,
Plymouth Meeting, PA

Nicholas B. Lydon, PhD
Granite BioPharma LLC
Jackson Hole, WY

Joseph R. Testa, PhD
Carol & Kenneth E. Weg Chair in Human Genetics,
Co-Director, Cancer Biology Program,
Co-Leader, Personalized Kidney Cancer Therapy Keystone Program,
Fox Chase Cancer Center, Philadelphia, PA

Felix Mitelman, MD, PhD
Professor, Department of Clinical Genetics,
University Hospital,
Lund, Sweden

Owen N. Witte, MD
Investigator, Howard Hughes Medical Institute Director, Broad Stem Cell Research Center at University of California, Los Angeles
Howard Hughes Medical Institute, UCLA
Los Angeles, CA